What is the recommended dosage of nortriptyline (tricyclic antidepressant) for treating depression or neuropathic pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nortriptyline Dosage for Depression and Neuropathic Pain

For neuropathic pain, nortriptyline should be started at 10-25 mg at bedtime and gradually increased to 50-150 mg daily, with optimal plasma concentrations maintained between 50-150 ng/mL. 1, 2

Dosing Recommendations

For Depression:

  • Initial dose: 25 mg 3-4 times daily or as a single bedtime dose 1
  • Maintenance dose: 50-150 mg/day
  • Maximum dose: 150 mg/day (doses above this are not recommended) 1
  • Elderly patients: Lower dosing of 30-50 mg/day in divided doses 1

For Neuropathic Pain:

  • Initial dose: 10-25 mg at bedtime 2
  • Titration: Increase by 25 mg every 3-7 days as tolerated 2
  • Target dose: 50-150 mg daily 2
  • Duration of adequate trial: 6-8 weeks with at least 2 weeks at maximum tolerated dosage 2

Pharmacokinetics and Monitoring

  • Plasma level monitoring: Maintain plasma concentrations between 50-150 ng/mL for optimal response 1
  • Higher concentrations: May be associated with more adverse effects, including cardiotoxicity 1
  • Administration: Can be given once daily at bedtime to minimize daytime sedation 2, 3
  • Bioavailability: Better than gabapentin (which has nonlinear pharmacokinetics) 4

Efficacy

  • Tricyclic antidepressants like nortriptyline are first-line treatments for neuropathic pain 2, 4
  • Secondary amine TCAs (nortriptyline, desipramine) are better tolerated than tertiary amines (amitriptyline, imipramine) though possibly slightly less efficacious 2
  • Analgesic effects occur at lower doses than those required for antidepressant effects 2
  • Onset of analgesic action is usually earlier than antidepressant effects 2

Adverse Effects and Precautions

  • Common side effects: Anticholinergic effects (dry mouth, constipation, urinary retention), dizziness, sedation 2
  • Cardiac considerations: Use with caution in patients with ischemic cardiac disease or ventricular conduction abnormalities 2
    • Obtain screening ECG for patients older than 40 years
    • Try to limit doses to less than 100 mg/day in patients with cardiac risk factors
  • Elderly patients: Require lower doses due to increased sensitivity to adverse effects 1
  • Renal impairment: Dose adjustment may be required 4

Treatment Algorithm

  1. Initial Assessment:

    • Confirm diagnosis of neuropathic pain or depression
    • Screen for contraindications (cardiac disease, glaucoma, urinary retention)
    • Obtain baseline ECG for patients over 40 years
  2. Initiation:

    • Start with 10-25 mg at bedtime for neuropathic pain
    • Start with 25 mg 3-4 times daily or once at bedtime for depression
  3. Titration:

    • Increase by 25 mg every 3-7 days as tolerated
    • Monitor for side effects at each dose increase
    • Aim for total daily dose of 50-150 mg
  4. Monitoring:

    • Assess efficacy after 6-8 weeks with at least 2 weeks at maximum tolerated dose
    • Consider plasma level monitoring to maintain 50-150 ng/mL
    • Monitor for adverse effects at each visit
  5. Maintenance:

    • Continue effective dose for long-term management
    • Periodically reassess need for continued treatment
    • Consider gradual dose reduction if symptoms resolve

Important Considerations

  • If partial response, consider adding another first-line agent (gabapentin, pregabalin) 2
  • If no response after adequate trial, switch to alternative first-line medication 2
  • Nortriptyline may be less effective for certain types of neuropathic pain (e.g., HIV-related neuropathies) 5
  • Once-daily dosing may improve adherence and is equally effective to divided doses 3

Caution

  • Avoid abrupt discontinuation; taper gradually to prevent withdrawal symptoms
  • Monitor closely in patients with comorbid conditions (cardiac disease, prostatic hypertrophy, glaucoma)
  • Consider drug interactions, particularly with other CNS depressants

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Managing Neuropathic Pain and Associated Edema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antidepressants for neuropathic pain.

The Cochrane database of systematic reviews, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.